berberine has been researched along with Primary Ovarian Insufficiency in 2 studies
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is a compound with anti-inflammatory, antioxidant, and anti-apoptotic activities." | 1.91 | Berberine protects cyclophosphamide and busulfan-induced premature ovarian insufficiency in mouse model. ( Fan, X; Guo, W; Liu, Z; Peng, Y; Sun, L; Wang, T; Yang, X; Zhou, J; Zou, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xue, W | 1 |
| Xue, F | 1 |
| Jia, T | 1 |
| Hao, A | 1 |
| Peng, Y | 1 |
| Sun, L | 1 |
| Guo, W | 1 |
| Liu, Z | 1 |
| Wang, T | 1 |
| Zou, T | 1 |
| Zhou, J | 1 |
| Yang, X | 1 |
| Fan, X | 1 |
2 other studies available for berberine and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology.
Topics: Animals; Berberine; Female; Granulosa Cells; Humans; Network Pharmacology; Primary Ovarian Insuffici | 2022 |
Berberine protects cyclophosphamide and busulfan-induced premature ovarian insufficiency in mouse model.
Topics: Animals; Berberine; Busulfan; Cyclophosphamide; Estradiol; Female; Humans; Mice; Primary Ovarian Ins | 2023 |